MING CHAO: Open Payments
NPI 1285821355 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$485 in 6 payments from 6 companies in 2025. Trend: 2023 $780 · 2024 $1,025 · 2025 $485
Food & beverage: $485
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 1 | $133 |
| Neurocrine BioSciences, Inc. | 1 | $126 |
| ACADIA Pharmaceuticals Inc | 1 | $118 |
| Lundbeck LLC | 1 | $60 |
| Gilead Sciences, Inc. | 1 | $24 |
| Smith+Nephew, Inc. | 1 | $24 |
Products named: NUPLAZID, REXULTI, Livdelzi, STRAVIX PL.
Industry payments across TX — which companies pay providers there.
